|
CUL4B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.186600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.964600E-01 |
| Normal-vs-Stage2 |
1.891570E-01 |
| Normal-vs-Stage3 |
1.521170E-01 |
| Normal-vs-Stage4 |
6.068800E-01 |
| Stage1-vs-Stage2 |
3.474000E-01 |
| Stage1-vs-Stage3 |
2.331800E-01 |
| Stage1-vs-Stage4 |
9.883400E-01 |
| Stage2-vs-Stage3 |
9.676600E-01 |
| Stage2-vs-Stage4 |
4.365200E-01 |
| Stage3-vs-Stage4 |
4.088000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.835000E-01 |
| Normal-vs-AfricanAmerican |
5.167000E-01 |
| Normal-vs-Asian |
6.848200E-01 |
| Caucasian-vs-AfricanAmerican |
1.349430E-01 |
| Caucasian-vs-Asian |
5.011200E-01 |
| AfricanAmerican-vs-Asian |
2.895800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.197400E-01 |
| Normal-vs-Female |
3.153800E-01 |
| Male-vs-Female |
8.304400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.504800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.768580E-01 |
| Normal-vs-Age(61-80Yrs) |
2.749000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.185800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.036610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.385000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.402000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.616600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.814200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.550200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.490600E-01 |
| Classical-VS-Follicular |
1.435900E-03 |
| Classical-VS-Other |
6.661600E-01 |
| Classical-VS-Normal |
9.341200E-01 |
| Tall-VS-Follicular |
1.987420E-01 |
| Tall-VS-Other |
9.138600E-01 |
| Tall-VS-Normal |
5.986000E-01 |
| Follicular-VS-Other |
5.453000E-01 |
| Follicular-VS-Normal |
3.005900E-02 |
| Other-VS-Normal |
6.769400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.516400E-02 |
| Normal-vs-N1 |
2.582600E-01 |
| N0-vs-N1 |
7.088600E-01 |
|
|
